Investorideas.com newswire, news and commentary for leading sectors

Wednesday, November 30, 2011

Clean Energy Trading Alert; Canadian Solar Inc. (NasdaqGS: CSIQ) Trading up over 20% On News

Point Roberts, WA - November 30, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in renewable energy stock research, releases a trading alert for solar stock, Canadian Solar Inc. (NasdaqGS: CSIQ). The stock is trading up at $3.02, up 0.49 (19.37%) 2:24PM EST with a high of $3.08.
The Company today reported announced the provision of 12,465 high-performing photovoltaic modules for a ground-mount solar power plant installed on a former mining site in the Italian city of Cavriglia (Arezzo).
The 10 MW plant, which has been operational since October contains over 40,000 modules including Canadian Solar's CS6P-P series, will reduce CO2 emissions by 5,531,000 kg. Constructed by Canadian Solar partner Coop Cellini Impianti Tecnologici, a highly competitive company known for their expertise and reliability in the renewable energy sector, installed the solar farm in the area of a former mining depot in the Tuscan province. It is connected to the local power grid and will be able to provide enough clean energy to serve the needs of some 7,000 homes.
Investorideas.com Newswire About Canadian Solar
Canadian Solar Inc. (NASDAQ: CSIQ - News) is one of the world's largest solar companies. As a leading vertically integrated provider of ingots, wafers, solar cells, solar modules and other solar applications, Canadian Solar designs, manufactures and delivers solar products and solar system solutions for on-grid and off-grid use to customers worldwide. With operations in North America, Europe, Australia and Asia, Canadian Solar provides premium quality, cost-effective and environmentally-friendly solar solutions to support global, sustainable development. For more information, visit www.canadiansolar.com.
Use the renewable energy stocks directory to research 1300 green stocks on global stock exchanges http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
About Investorideas.com - a leader in cleantech investor research
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Visit Investorideas.com green and renewable showcase stocks and more investor research in the sector: http://www.investorideas.com/Companies/RenewableEnergy/ or www.renewableenergystocks.com
Investors - sign up for free green stocks trading alerts and news
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks onFacebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Investorideas.com is not compensated by CSIQ
For more information about Investorideas.com contact:
800.665.0411
Tuesday's TSX Trading Leaders: (TSX:BBD.B), (TSX:ML), (TSX:CM), (TSX:FBK)

November 30, 2011 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for TSX trading leaders for November 29, 2011. The Standard & Poor's/TSX Composite Index gained for the second consecutive day and added 92.29 (0.79%) to close the day at 11,732.50.
Bombardier, Inc. (TSX:BBD.B) was the top traded stock on the TSX, ending lower by 0.12 (-3.15%) to close at C$3.69 with more than 7.81 million shares exchanged hands, compared to its average volume of 7.75 million shares following The bankruptcy protection filing by American Airlines' parent company Tuesday. However, analysts believe that this won't affect Bombardier Inc.
Cline Mining Corp. (TSX: CMK) fell 0.12 (-7.19%) to end at C$1.55 on over 5.73 million shares, compared to its 30-day average volume of 3.23 million shares, extending its weekly loss of over 13%. The stock has a 52-week range of $0.99-$5.04.
Mercator Minerals, Ltd. (TSX:ML) surged 0.15 (9.80%) to finish at C$1.68 on over 4 million shares, compared to its average volume of 2.49 million as prices of crude oil jumped over 2%. Mercator Minerals Ltd. is a natural resource company engaged in the mining, development and exploration of its mineral properties in Arizona, in the United States of America and Mexico.
Fibrek Inc. (TSX:FBK) shares soared 0.230 (31.94%) to close the day at C$0.950 on over 5 million shares after the micro cap miner reported additional gold and silver intercepts on its 100% owned Burns Block property in the Rainy River District of northwestern Ontario, which included 30 metres grading 12.98 grams per tonne (g/t) gold.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411
Tuesday's NASDAQ Winners: MAGS, CEDC, SLXP, SPMD

POINT ROBERTS, November 30 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Tuesday November 29th. NASDAQ fell 11.83 (-0.47%) to end at 2,515.51.
Magal Security Systems Ltd. (USA) (NASDAQ:MAGS) was the biggest percentage winner and soared 1.78 (67.17%) to $4.43 after the company said that revenues for the third quarter of 2011 increased 107% to a record $27.7 million, as compared with $13.4 million in the third quarter of 2010. The company reported net income of $7.1 million, as compared with a net loss of $799,000 in the third quarter of 2010.
Central European Distribution Corp (NASDAQ:CEDC) shares gained 0.99 (29.12%) to $4.39 on heavy volume of 7.57 million shares, compared to its average volume of 2.91 million shares after Russian Standard Vodka purchased a 9.9% stake in its Polish rival, according to a regulatory filing late Monday.
Salix Pharmaceuticals, Ltd. (NASDAQ:SLXP) increased by 4.63 (12.64%) to $41.27. Salix Pharmaceuticals, Ltd. is a pharmaceutical company engaged in acquiring, developing and commercializing prescription drugs used in the treatment of a variety of gastrointestinal disorders, which are those affecting the digestive tract.
SuperMedia Inc (NASDAQ:SPMD) shares jumped 0.22 (11.70%) to $2.10, recovering from its sharp fall of over 22% during the past week. SuperMedia Inc. (SuperMedia), formerly Idearc Inc., is a yellow pages directory publisher in the United States. SuperMedia also offer online advertising solutions.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising. www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com

Tuesday, November 29, 2011

Monday's Renewable Energy Stocks Trading; (OTC:CWET), (NASDAQ:FSLR), (NYSE:LDK), (NYSE:LXU), (NASDAQ:AMSC)


Point Roberts, WA - November 29, 2011 (Investorideas.com renewable energy/green newswire) Investorideas.com, a leader in cleantech investor research, reports on trading for renewable energy stocks for 28th October. Renewable energy stocks moved up with general market sentiment and yesterday�s rally following strong retail results from Black Friday shopping.
Solar stock, First Solar, Inc. (NASDAQ:FSLR) was one of the biggest gainers, moving up $4.24 (10.52%) to close at $44.56 with the broader market rally. The stock is bouncing back from its sharp fall. The stock has a 52-week range of $40.05-$175.45. The company has market capitalization of $3.85 billion.
Chinese solar stock, LDK Solar Co., Ltd (ADR) (NYSE:LDK) also added 0.30 (9.62%) to $3.42 on hefty volume of 2.01 million shares, extending its weekly gain to over 17%. The stock has a 52-week range of $2.55-$14.97. The company has market capitalization of $495.77 million.
Wind stock, Clean Wind Energy Tower Inc (OTC: CWET) surged 5.26% to $0.20 on over 196K shares, compared to its 30-day average volume of 9.3K shares. Clean Wind Energy Tower, Inc., formerly Superior Silver Mines, Inc., focuses on designing, developing and constructing large downdraft towers that use non-toxic natural elements to generate electricity and clean water economically (Downdraft Towers) by integrating and synthesizing various proven, as well as emerging technologies.
LSB Industries, Inc. (NYSE:LXU) jumped 2.20 (7.84%) to $30.25, recovering from its sharp fall of 15% during the past week. LSB Industries, Inc. (LSB) is a diversified holding company. LSB and its wholly owned subsidiaries owns all of its businesses consisting of the Climate Control Business engaged in the manufacturing and selling of a range of air conditioning.
American Superconductor Corporation (NASDAQ:AMSC) added 0.16 (4.17%) to close at $4 on over 953K shares, bouncing back from its fall of 8% during the previous week.
Owens Corning (NYSE:OC) climbed 0.83 (3.21%) to $26.71 on over 1.26 million shares after falling over 8% in the past week.
Modine Manufacturing Co. (NYSE:MOD) jumped 0.57 (7.04%) to end the day at $8.67.
Ocean Power Technologies, Inc. (NASDAQ:OPTT) rose 0.48 (14.85%) to close at $3.73.
Power Efficiency Corporation (OTC: PEFF) soared 0.0340 (94.44%) to $0.0700.
Research more wind stocks with the renewable energy stocks directory:
http://www.investorideas.com/Companies/RenewableEnergy/Stock_List.asp
Visit the Clean Wind Energy Tower Inc (OTC: CWET) showcase page at Investorideas.com: http://www.investorideas.com/CO/CWE/
Visit the City Windmills showcase profile at Investorideas.com
http://www.investorideas.com/CO/CYW/
About Investorideas.com and our Green Investor content:
Investorideas.com was on the of the first investor sites covering investing in water and renewable energy stocks and has become a global go-to destination for investors researching the cleantech sector, with stock directories, company news, commentary from experts, research reports and industry resources and links. Investors can follow solar stocks commentary on our site with solar expert, J. Peter Lynch.
Sign up at Investor Ideas for free investor alerts including news on wind stocks
http://www.investorideas.com/Resources/Newsletter.asp
Follow Renewable Energy Stocks on Facebook.com
http://www.facebook.com/renewableenergystocks
Disclaimer/ Disclosure: The following news is part of the Clean Wind Energy Tower, Inc. (OTCBB: CWET) advertising program with Investorideas.com. Clean Wind Energy, Inc. compensates investorideas.com (one thousand five hundred per month, 100,000 144 shares) to be showcased as a renewable energy stock within its hub of sites and blogs .City Windmills is a paid showcase Frankfurt wind stock , 3500 per month plus 5000 shares
Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and its management and is not the opinion of Investorideas.com. Learn more: www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
For more information about Investorideas.com contact:
800.665.0411
TSX Stocks to Watch; Monday's Trading Leaders: (TSX: CMQ.UN), (TSX: HAT), (TSX: S), (TSX: RY)

November 29, 2011 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for TSX trading leaders for November 28, 2011. The Standard & Poor's/TSX Composite Index bounced back 178.15 points (1.55%) to close the day at 11,640.21.
CANMARC REIT (TSX:CMQ.UN) was the top traded stock on the TSX and ended higher by 2.52 (18.98%) to C$5.80 with more than 8.06 million shares exchanged hands, compared to its average volume of 175K shares. Cominar Real Estate Investment Trust, is planning to create Canada's second-largest diversified property portfolio, has offered to buy Canmarc REIT in a hostile bid that values its rival at C$838 million ($800.4 million).
Hathor Exploration Limited (TSX:HAT) fell 0.36 (-7.13%) to end at C$4.69 on over 7.73 million shares, compared to its 30-day average volume of 2.85 million shares after Cameco decided to cancel its bid for uranium explorer Hathor Exploration, clearing the way for Rio Tinto Ltd.'s (RIO) planned C$4.70-a-share, or C$654 million, offer.
Suncor Energy Inc. (TSX:SU) surged 0.77 (2.74%) to close at C$28.91 on over 5.53 million shares, compared to its average volume of 5.15 million as prices of crude oil jumped over 2%. Suncor Energy Inc said on Monday it began restarting units at its Sarnia, Ontario, refinery over the weekend after shutting them a week earlier due to a leak.
Royal Bank of Canada (TSX: RY) shares added 0.92 (2.12%) to close the day at C$44.32 on over 4.27 million shares with the broader market on hopes of Europe optimism. Royal Bank of Canada (RBC) is a diversified financial services company. RBC provides personal and commercial banking, wealth management services, insurance, corporate and investment banking and transaction processing services on a global basis.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411
Biotech stocks News; BioSante Pharmaceuticals (NASDAQ: BPAX) Announces Issuance of New LibiGel® Method of Use Patent

LINCOLNSHIRE, Ill. - November 29, 2011 (Investorideas.com newswire) - BioSante Pharmaceuticals, Inc. (NASDAQ: BPAX) today announced the issuance of a new U.S. patent covering the �method of use� of LibiGel (testosterone gel) for treating female sexual dysfunction (FSD) and hypoactive sexual desire disorder (HSDD). The patent covers methods for treating FSD and HSDD and also includes using a metered dosage device to deliver the defined dose of the testosterone formulation in LibiGel. U.S. Patent No. 8,067,399, which issued today, will expire on December 29, 2028. The two named inventors of this new patent are a current and a former employee of BioSante.
"We are very pleased that this new LibiGel patent has issued. The patent protects the use of LibiGel in treating FSD and HSDD, and the bottle we used in our clinical work, as well as in the intended commercial product, and extends our patent protection to the end of 2028,� said Stephen M. Simes, BioSante president and CEO. �Our objective has been to continue to strengthen our intellectual property covering LibiGel and this patent is a major achievement in that direction."
About LibiGel®
LibiGel is a testosterone gel in Phase III clinical development for the treatment of women who suffer from female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD). The completed Phase III efficacy trials are double-blind, placebo-controlled trials that enrolled over 500 surgically menopausal women each for six-months of therapy, approximately half of whom were taking concomitant estrogen therapy and half of whom took no concomitant estrogen therapy. The completed efficacy trials were conducted according to an FDA-agreed special protocol assessment (SPA) agreement. LibiGel is absorbed quickly through the skin after applying a once-daily pea-sized topical application on the upper arm that delivers testosterone to the bloodstream evenly over time.
In addition, BioSante is conducting the Phase III LibiGel safety study, a randomized, double-blind, placebo-controlled, multi-center, cardiovascular (CV) events and breast cancer study that has completed enrollment of 3,656 women and has accrued over 5,100 women-years of exposure, to date. The study will continue for a total of five years; however, BioSante will use the safety study data as part of an NDA submission after the last subject enrolled has completed 12 months of exposure to LibiGel or placebo.
The LibiGel safety study is tracking a predefined list of CV events, in agreement with the FDA, including CV death, myocardial infarction and stroke in women 50 years of age or older and suffering from at least two CV risk factors including hypertension and diabetes. The objective of the safety study is to demonstrate the relative safety of testosterone compared to placebo in the number of CV events. The incidence of breast cancer also is being tracked over the course of the study. The study represents the largest data base of the safety of testosterone in women.
Upon completion of the statistical analyses of efficacy trials and the safety study, BioSante intends to submit an NDA to the FDA, requesting approval of LibiGel for the treatment of HSDD in menopausal women. The NDA submission is targeted for the fourth quarter of 2012.
About BioSante Pharmaceuticals, Inc.
BioSante is a specialty pharmaceutical company focused on developing products for female sexual health and oncology. BioSante's lead products include LibiGel® (transdermal testosterone gel) for the treatment of female sexual dysfunction (FSD), specifically hypoactive sexual desire disorder (HSDD), which is in Phase III clinical development according to a U.S. Food and Drug Administration (FDA) Special Protocol Assessment (SPA). BioSante's first FDA-approved product is Elestrin™ (estradiol gel) indicated for the treatment of hot flashes associated with menopause, marketed in the U.S. by Azur Pharma, BioSante's licensee. BioSante also is developing a portfolio of cancer vaccines, four of which have been granted Orphan Drug designation, and are currently in several Phase II clinical trials. Other BioSante products are Bio-T-Gel™, a testosterone gel for male hypogonadism, for which an NDA is pending, licensed to Teva Pharmaceuticals, and an oral contraceptive in Phase II clinical development. Additional information is available online at: www.biosantepharma.com.
Forward-Looking Statements
To the extent any statements made in this news release deal with information that is not historical, these are forward-looking statements under the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements about BioSante's plans, objectives, expectations and intentions with respect to future operations and products, the timing of anticipated regulatory submissions and other statements identified by words such as �will,� �continue,� �could,� �believe,� �intends,� �continue,� �expects,� �anticipates,� �estimates,� �may,� other words of similar meaning, derivations of such words or the use of future dates. Forward-looking statements by their nature address matters that are, to different degrees, uncertain. Uncertainties and risks may cause BioSante's actual results to be materially different than those expressed in or implied by BioSante's forward-looking statements. For BioSante, particular uncertainties and risks include, among others, the difficulty of developing pharmaceutical products, obtaining regulatory and other approvals and achieving market acceptance; the marketing success of BioSante's licensees or sublicensees; the success of clinical testing; and BioSante's need for and ability to obtain additional financing. More detailed information on these and additional factors that could affect BioSante's actual results are described in BioSante's filings with the Securities and Exchange Commission, including its most recent annual report on Form 10-K and subsequent quarterly report on Form 10-Q. All forward-looking statements in this news release speak only as of the date of this news release. BioSante undertakes no obligation to update or revise any forward-looking statement, whether as a result of new information, future events or otherwise.
Contact:
For Investors:
The Trout Group LLC
Tricia Swanson
(646) 378-2953
tswanson@troutgroup.com
or
For Media:
Harris D. McKinney, Inc.
Alan Zachary
312-506-5220
azachary@harrisdmckinney.com
BioSante Pharmaceuticals, Inc: (NASDAQ: BPAX) is a featured showcase biotech/pharma stock on Investorideas.com
Request news, updates and trading alerts on BPAX and other showcase stocks http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leading global investor and industry research resource portal specialized in sector investing, covering leading industry sectors including biotech and pharma stocks.
Disclaimer: The following news/content is paid for as part of the BPAX showcase program (two thousand per month) Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising.
Investorideas.com Disclaimer: http://www.investorideas.com/About/Disclaimer.asp  
Investorideas.com Disclosure: http://www.investorideas.com/About/News/Clientspecifics.asp  
Source: Investorideas.com, BioSante, Investorideas.com
800 665 0411 cvanzant@investorideas.com

Monday, November 28, 2011

China Stocks News; CDII (NasdaqGM:CDII) VP Richard Galterio discusses New Business ventures and Global opportunities

Deerfield Beach, Florida - November 28, 2011 (Investorideas.com Newswire) � CDII (NASDAQ:CDII) discusses state of business and global operations with Richard Galterio, VP of Investor Relations.
Headquartered in Deerfield Beach, Florida, China Direct Industries acquires controlling interests of Chinese business entities. We operate two primary business segments: Magnesium and Basic Materials. We are committed to improving the quality and performance of each subsidiary by providing an array of resources to augment their efficiency and growth. These resources include management advice, investment capital, business development services, strategic planning, internal control, macroeconomic industry analysis, and financial management. Through this ownership control, we provide resources, enabling these subsidiaries to successfully expand their operations.
In addition, we provide consulting services to Chinese entities seeking to compete in a global economy. These services include strategic planning, business development, investment and financing assistance, M&A planning and analysis, modeling and valuation analysis, financial management, SEC report filings and management, SOX 404 compliance, and investor and public relations services.
With offices in the United States and China, China Direct Industries is comprised of both Chinese and American business professionals eager to develop creative solutions to access the growing Chinese economy. Employing a multicultural team which has been operating successfully within the landscape since 2001, our organization presents a series of advantages critical to the success of Chinese entities.
About China Direct Industries
IncChina Direct Industries, Inc. (NASDAQ:CDII), is a U.S. based company that sources, produces and distributes industrial commodities in China and the Americas and provides business and financial consulting services. Headquartered in Deerfield Beach, Florida with corporate offices in Shanghai, China Direct Industries' unique infrastructure provides a platform to expand business opportunities globally while effectively and efficiently accessing the U.S. capital markets.
For more information about China Direct Industries, please visit http://www.cdii.net.
Contact Information:
China Direct Industries, Inc.
Richard Galterio or Lillian Wong
Investor Relations
Phone: 1-877-China-57
Email: richard.galterio@cdii.net
lillian.wong@cdii.net
China Direct Industries, Inc. (NasdaqGM:CDII) is a featured stock on Investorideas.com
Visit the company profile
Disclosure/ disclaimer: Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. All information published is from public filings , news , SEC filings and or company comments and quotes .China Direct Industries, Inc.(NasdaqGM: CDII ) One month online marketing paid for by third party Pearl Group; twelve thousand five hundred, to include CFA Commentary, email distribution with other Investorideas.com partners and network of online media which are also compensated as part of this overall marketing (please read their disclosures)
Friday's NASDAQ Winners: POZN, AMCF, WWIN, SPRD

POINT ROBERTS - November 28, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Friday November 25th. NASDAQ closed with a loss of 18.57 (-0.75%) to 2,441.51. In Monday morning markets, US stocks are up sharply following Black Friday retail results.
POZEN Inc. (NASDAQ:POZN) was the top percentage winner and soared 1.12 (44.80%) to end at $3.62 after the company's news it entered into an accord with Canada's CPPIB Credit Investments (CII) to sell the company's right to receive future royalty payments arising from US sales of MT 400, including migraine drug Treximet, (sumatriptan/naproxen sodium) which incorporates the US company's MT 400 technology.
Andatee China Marine Fuel Services Corporation (NASDAQ:AMCF) surged 0.39 (11.34%) to close at $3.83 after Andatee China Marine said its chief executive aims to acquire all of the outstanding shares of Andatee that he doesn't already own in a tender offer that values the company at roughly $41.3 million.
Winner Medical Group, Inc (NASDAQ:WWIN) increased by 0.23 (7.21%) to finish a t $3.42. The company announced that it will release financial results for its fourth quarter and fiscal 2011 on Wednesday, November 30, 2011, before the market opens.
Spreadtrum Communications, Inc (ADR) (NASDAQ:SPRD) also jumped 1.58 (6.82%) to end at $24.75. Spreadtrum Communications, Inc. is a fabless semiconductor company that designs, develops and markets baseband processor, radio frequency (RF) transceiver and turnkey solutions for the wireless communications and mobile television market.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
TSX Stocks to Watch; Friday's Trading Leaders: (TSX: WED), (TSX: SU), (TSX: RY), (TSX: MFC)

November 28, 2011 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for TSX trading leaders for November 25, 2011. The Standard & Poor's/TSX Composite Index ended lower by 23.26 (-0.20%) to close the day at 11,462.06.
The Westaim Corporation (TSX:WED) was the most active stock on the TSX Friday and ended higher by 0.020 (3.70%) to C$0.560 with more than 7.38 million shares exchanged hands, compared to its average volume of 609K shares. Over the past year, the stock has been trading within a narrow range of $0.43-$0.62. The company has market capitalization of $324.99 million.
Suncor Energy Inc. (TSX:SU) fell 0.61 (-2.12%) to close at C$28.14 on over 3.50 million shares, compared to its 30-day average volume of 5.15 million shares. Suncor Energy explores for, acquires, develops, produces and markets crude oil and natural gas in Canada and internationally, and it transports and refines crude oil and market petroleum and petrochemical products primarily in Canada.
Royal Bank of Canada (TSX:RY) lost 0.50 (-1.14%) to end at C$43.40 on over 2.81 million shares, compared to its average volume of 3.45 million shares after hitting a new 52-week low of $43.30 earlier in the session. Royal Bank of Canada (RBC) is a diversified financial services company. RBC provides personal and commercial banking, wealth management services, insurance, corporate and investment banking and transaction processing services on a global basis.
Manulife Financial Corp. (TSX:MFC) shares gained 0.07 (0.65%) to close the day at C$10.84 on over 2.62 million shares. For Manulife Financial, the present is Canada and the United States, but the future will increasingly be Southeast Asia, where its insurance business is growing by 30 percent a year with the potential to improve, a senior executive said on Wednesday.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411

Biotech Investor Alert for (OTC: AEMD), (Nasdaq:VRUS), (VRTX); Hepatitis C Virus (HCV) Treatments

POINT ROBERTS - November 28, 2011 - www.InvestorIdeas.com issues a biotech investor alert for Pharmasset, Inc. (Nasdaq:VRUS), Vertex Pharmaceuticals (VRTX) and Aethlon Medical, Inc. (OTCBB: AEMD), three stocks involved in the treatment of Hepatitis C Virus (HCV).
Over 170 million people worldwide are chronically infected with Hepatitis C. The sector made headlines earlier this week as Pharmasset, Inc. (Nasdaq:VRUS), traded up over 84% on acquisition news.
Gilead Sciences, Inc. (Nasdaq:GILD) and Pharmasset, Inc. (Nasdaq:VRUS) reported the companies have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash.
Pharmasset (Nasdaq:VRUS) has three clinical-stage product candidates for the treatment of chronic hepatitis C virus (HCV) advancing in trials in various populations. The company's lead product candidate, PSI-7977, an unpartnered uracil nucleotide analog, has recently been advanced into two Phase 3 studies in genotype 2 and 3 patients. Both studies will utilize 12 weeks of treatment with PSI-7977 in combination with ribavirin. One study will compare this all-oral regimen against 24 weeks of the standard-of-care pegylated interferon/ribavirin in treatment-naïve patients, and the second study will compare the all-oral regimen to placebo in interferon-intolerant/ineligible patients. A third Phase 3 study in genotype 1 patients will be initiated in the second half of 2012, the design of which is dependent on the outcome of Phase 2 studies which are evaluating PSI-7977 in various combinations in genotype 1-infected patients. If successful, this strategy could lead to an initial U.S. regulatory approval of PSI-7977 in 2014. PSI-938, an unpartnered guanosine nucleotide analog, is being tested in a Phase 2b interferon-free trial as monotherapy and in combination with PSI-7977 in subjects with HCV of all viral genotypes. Mericitabine (RG7128), a cytidine nucleoside analog, is partnered with Roche and is being evaluated in three Phase 2b trials. Roche is responsible for all aspects of the development of mericitabine.
Gilead's research and development portfolio includes seven unique molecules in various stages of clinical development for the treatment of HCV.
James A. Joyce, Chairman and CEO of Aethlon Medical, Inc. (OTCBB: AEMD) recently updated shareholders on November 16 th, "Our Hemopurifier® has demonstrated broad-spectrum capabilities against viral pathogens, including HCV, the human immunodeficiency virus (HIV), and a variety of tested bioterror and pandemic threats. Specific to treating HCV, we previously conducted studies that demonstrated the safe administration of our Hemopurifier® in HCV-infected dialysis patients whose average viral load reductions exceeded 50% during each four-hour treatment. These results were obtained in the absence of any drug therapy."
Full news : http://finance.yahoo.com/news/Aethlon-Medical-Releases-prnews-4279719933.html?x=0&l=
Vertex Pharmaceuticals Inc (VRTX ) announced earlier in November its interim results from ZENITH, an ongoing Phase 2 study designed to assess the safety, tolerability and efficacy of multiple 12- and 24-week response-guided treatment regimens with VX-222 (100mg or 400mg), its lead polymerase inhibitor in development, in combination with INCIVEK™ (telaprevir ) tablets, pegylated-interferon and ribavirin in people with genotype 1 chronic hepatitis C who were new to treatment. On the basis of the results announced today and previously announced data from other treatment arms of the ZENITH study, Vertex intends to start a Phase 3 study to evaluate a total treatment duration of 12 weeks with this four-drug regimen in treatment naïve and relapser patients with genotype 1 chronic hepatitis C.
More about Aethlon Medical (OTCBB: AEMD)
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com.
Visit the AEMD showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC (OTC BB: AEMD) Showcase biotech, biodefense and defense stock on Investorideas.com ($one thousand five hundred per month, $five thousand per month in 144 stock) Effective March 15, 2011      
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com

Friday, November 25, 2011

Hepatitis C Virus (HCV) Biotech and Pharma Stock News: (OTC: AEMD), (Nasdaq:VRUS), (VRTX)

POINT ROBERTS, November 25, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, issues a biotech/pharma investor snapshot for stocks involved in the treatment of Hepatitis C Virus (HCV). Over 170 million people worldwide are chronically infected with Hepatitis C. The sector made headlines earlier this week as Pharmasset, Inc. (Nasdaq:VRUS), traded up over 84% on acquisition news.
Gilead Sciences, Inc. (Nasdaq:GILD) and Pharmasset, Inc. (Nasdaq:VRUS) reported the companies have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash.
What does this mean for the sector? Are there other potential acquisitions? Some say this acquisition makes Vertex Pharmaceuticals Inc (VRTX) look relatively cheap.
Pharmasset (Nasdaq:VRUS) has three clinical-stage product candidates for the treatment of chronic hepatitis C virus (HCV) advancing in trials in various populations. The company's lead product candidate, PSI-7977, an unpartnered uracil nucleotide analog, has recently been advanced into two Phase 3 studies in genotype 2 and 3 patients. Both studies will utilize 12 weeks of treatment with PSI-7977 in combination with ribavirin. One study will compare this all-oral regimen against 24 weeks of the standard-of-care pegylated interferon/ribavirin in treatment-naïve patients, and the second study will compare the all-oral regimen to placebo in interferon-intolerant/ineligible patients. A third Phase 3 study in genotype 1 patients will be initiated in the second half of 2012, the design of which is dependent on the outcome of Phase 2 studies which are evaluating PSI-7977 in various combinations in genotype 1-infected patients. If successful, this strategy could lead to an initial U.S. regulatory approval of PSI-7977 in 2014. PSI-938, an unpartnered guanosine nucleotide analog, is being tested in a Phase 2b interferon-free trial as monotherapy and in combination with PSI-7977 in subjects with HCV of all viral genotypes. Mericitabine (RG7128), a cytidine nucleoside analog, is partnered with Roche and is being evaluated in three Phase 2b trials. Roche is responsible for all aspects of the development of mericitabine.
Gilead's research and development portfolio includes seven unique molecules in various stages of clinical development for the treatment of HCV.
James A. Joyce, Chairman and CEO of Aethlon Medical, Inc. (OTCBB: AEMD) recently updated shareholders on November 16 th, "Our Hemopurifier® has demonstrated broad-spectrum capabilities against viral pathogens, including HCV, the human immunodeficiency virus (HIV), and a variety of tested bioterror and pandemic threats. Specific to treating HCV, we previously conducted studies that demonstrated the safe administration of our Hemopurifier® in HCV-infected dialysis patients whose average viral load reductions exceeded 50% during each four-hour treatment. These results were obtained in the absence of any drug therapy."
Full news: http://finance.yahoo.com/news/Aethlon-Medical-Releases-prnews-4279719933.html?x=0&l=
Vertex Pharmaceuticals Inc (VRTX) announced earlier in November its interim results from ZENITH, an ongoing Phase 2 study designed to assess the safety, tolerability and efficacy of multiple 12- and 24-week response-guided treatment regimens with VX-222 (100mg or 400mg), its lead polymerase inhibitor in development, in combination with INCIVEK™ (telaprevir) tablets, pegylated-interferon and ribavirin in people with genotype 1 chronic hepatitis C who were new to treatment. On the basis of the results announced today and previously announced data from other treatment arms of the ZENITH study, Vertex intends to start a Phase 3 study to evaluate a total treatment duration of 12 weeks with this four-drug regimen in treatment naïve and relapser patients with genotype 1 chronic hepatitis C.
More about Aethlon Medical (OTCBB: AEMD)
The Aethlon Medical mission is to create innovative medical devices that address unmet medical needs in cancer, infectious disease, and other life-threatening conditions. Our Aethlon ADAPT™ System is a revenue-stage technology platform that provides the basis for a new class of therapeutics that target the selective removal of disease enabling particles from the entire circulatory system. The Aethlon ADAPT™ product pipeline includes the Aethlon Hemopurifier® to address infectious disease and cancer; HER2osome™ to target HER2+ breast cancer, and a medical device being developed under a contract with the Defense Advanced Research Projects Agency (DARPA) that would reduce the incidence of sepsis in combat-injured soldiers and civilians. For more information, please visit www.aethlonmedical.com.
Visit the AEMD showcase page on Investorideas.com
http://www.investorideas.com/CO/AEMD
Get biotech news and stock alerts
http://www.investorideas.com/Resources/Newsletter.asp
Research more biotech stocks at the Biotech stocks Directory: http://www.investorideas.com/BIS/Stock_List.asp
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer/ Disclosure : The Investorideas.com is a third party publisher of news and research Our sites do not make recommendations, but offer information portals to research news, articles, stock lists and recent research. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. This site is currently compensated by featured companies, news submissions and online advertising. AETHLON MEDICAL INC (OTC BB: AEMD) Showcase biotech, biodefense and defense stock on Investorideas.com ($one thousand five hundred per month, $five thousand per month in 144 stock) Effective March 15, 2011       
BC Residents and Investor Disclaimer: Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
800-665-0411
Source - www.Investorideas.com
TSX Stocks to Watch; Thursday's Trading Leaders: (TSX: AAB), (TSX: NRG), (TSX: MNB), (TSX: CEE)

November 25, 2011 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for TSX trading leaders for November 24, 2011. The Standard & Poor's/TSX Composite Index ended lower by 86.39 (-0.75%) to close the day at 11,485.32.
Aberdeen International Inc. (TSX: AAB) was the most active stock on the TSX and ended higher by 0.020 (3.23%) to close at C$0.64, rebounding from its recent lows. Recently, the company announced that the value of its investment portfolio as at October 31, 2011, the end of its 2012 third fiscal quarter, was approximately $100.1 million including a cash balance of $7.4 million.
Alter Nrg Corp. (TSX: NRG) soared 0.180 (24.00%) to end at C$0.93 on over 1.29 million shares, compared to its 30-day average volume of 60K shares. Alter Nrg Corp. announced that it has received notification of a proposed agreement (the agreement) to be finalized by the middle of December for Alter to be the selected provider for the engineering, fabrication and construction of a plasma gasifier for installation at the proposed Tees Valley Renewable Energy Facility in Northeast England.
Mirabela Nickel Limited (TSX:MNB) added 0.04 (2.65%) to finish at C$1.55 on over 1.27 million shares, compared to its average volume of 623K shares after the company announced Record sales of nickel in concentrate for the quarter of 4,228 tonnes. A 15% decrease in unit cash costs for the quarter to US$6.71/lb (Q2 2011: US$7.85/lb) and expected to continue to decrease further during the fourth quarter.
Centamin Egypt Limited (TSX: CEE) shares fell 0.05 (-3.55%) to close the day at C$.36 on over 1.12 million shares. Centamin Egypt Limited (Centamin) is a mineral exploration development and mining company. Centamin is engaged in the exploration for precious and base metals, production of gold and ongoing development at the Sukari project.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas - Become a Member
Investorideas.com Members currently have 24/7 online access to the exclusive subscriber-only 13 stock directories in leading sectors including nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news!
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising .
www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894
Source - Investorideas.com
800-665-0411

Thursday, November 24, 2011

Wednesday's NASDAQ Top Gainers: PNBC, TSPT, AMCN, OPTT

POINT ROBERTS - November 24, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Wednesday November 23rd. NASDAQ closed with a sharp loss of 61.20 (-2.43%) to 2,460.08.
Princeton National Bancorp, Inc. (NASDAQ:PNBC) was the top percentage winner soaring 0.32 (17.77%) to end at $2.12, extending its weekly gains to over 110% on heavy volume. The stock has a 52-week range of $0.86-$7.32. The company has market capitalization of $7.07 million.
Transcept Pharmaceuticals, Inc. (NASDAQ:TSPT) surged 0.73 (11.04%) to finish at $7.34, after the company said that U.S. Food and Drug Administration (FDA) has approved Intermezzo (zolpidem tartrate sublingual tablet) C-IV for use as needed for the treatment of insomnia when a middle-of-the-night awakening is followed by difficulty returning to sleep.
AirMedia Group Inc. (ADR) (NASDAQ:AMCN) increased by 0.28 (10.41%) to end at $2.97 after the advertisement business in China continues to be a strong growth story. Chinese advertisers spent approximately $33 billion on advertising last year, and that number is expected to nearly double by 2014.
Ocean Power Technologies, Inc. (NASDAQ:OPTT) jumped 0.28 (10.04%) to close at $3.07, rebounding from its recent low. The stock has a 52-week range of $2.33-$6.80. The company has market capitalization of $31.91 million.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com
TSX Stocks to Watch; Wednesday’s Trading Leaders:  (TSX: AAA), (TSX: LSG), (TSX: LUN), (TSX: ASR)

Mining Stocks Most Active for TSX Investors- But Markets Fall 
November 24, 2011 - Investorideas.com, a leader in sector research for independent investors issues a trading alert for TSX trading leaders for November 23, 2011. The Standard & Poor's/TSX Composite Index fell 223.48 (1.89%) to close the day at 11,571.71.

ALLANA POTASH CORP (TSX: AAA) was the most actively traded stock on the TSX and ended lower by 3.42% to C$1.13 after. Earlier this week, the company announced the results of an independent Preliminary Economic Assessment ("PEA") prepared by Ercosplan Ingenieurgesellschaft Geotechnik und Bergau ("ERCOSPLAN") on its Danakhil Potash Project in Ethiopia (the "Project").
Lake Shore Gold Corp.  (TSX: LSG) also ended lower by 0.11 (-8.05%) to close at C$1.37 on over 8.18 million shares, compared to its 30-day average volume of 4.67 million shares. Earlier this week, the company announced the completion of an initial National Instrument ("NI") 43-101 resource estimate for the Company's wholly owned Fenn-Gib property located approximately 60 km's east of Timmins, Ontario.
Lundin Mining Corporation (TSX: LUN) fell 0.13 (-3.74%) to C$3.35 on over 4.20 million shares, compared to its average volume of 5.68 million shares. Lundin Mining is a diversified Canada-based base metals mining company with operations in Portugal, Sweden, Spain and Ireland, producing copper, zinc, lead and nickel.
Alacer Gold Corp (TSX: ASR) shares added 0.18 (1.67%) to close the day at C$10.93 on over 2.85 million shares. Alacer Gold Corp. (Alacer), formerly Anatolia Minerals Development, is an intermediate gold producer. As of December 31, 2010, the Company held interests in four operating gold mines in Australia and Turkey.
About InvestorIdeas.com: Big Ideas for small cap Investors
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.

Sign up for the free investor news and stock alerts http://www.investorideas.com/Resources/Newsletter.asp

Join Investor Ideas – Become a Member
Investorideas.com Members currently have 24/7 online access to the  exclusive subscriber-only 13 stock directories in leading sectors including  nanotech, renewable energy, water and energy stocks. Get stock alerts and hot news! 
Visit the Investor Ideas membership page to learn more at: http://www.investorideas.com/membership/

Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook   http://www.facebook.com/Investorideas

Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising.

www.InvestorIdeas.com/About/Disclaimer.asp
BC Residents and Investor Disclaimer : Effective September 15 2008 - all BC investors should review all OTC and Pink sheet listed companies for adherence in new disclosure filings and filing appropriate documents with Sedar. Read for more info: http://www.bcsc.bc.ca/release.aspx?id=6894

Source – Investorideas.com
800-665-0411

Wednesday, November 23, 2011

Tuesday's NASDAQ Top Percentage Winners: WCAA, FMCN, BRCD, CSIQ

POINT ROBERTS - November 23, 2011 - www.InvestorIdeas.com, a global investor research portal for independent investors, reports on top percentage gainers on the NASDAQ for Tuesday November 22nd. NASDAQ closed almost flat with a loss of 1.86 (-0.07%) at 2,521.28.
WCA Waste Corporation (NASDAQ:WCAA) was the biggest percentage gainer, gaining $0 .74 (18.41%) to close at $4.76. The stock has a 52-week range of $3.01-$6.27. WCA Waste Corporation (WCA Waste) is a vertically integrated, non-hazardous solid waste management company providing non-hazardous solid waste collection, transfer, processing, and disposal services in the south and central regions of the United States.
Focus Media Holding Limited (ADR) (NASDAQ:FMCN) added 2.27 (14.71%) to end at $17.70, rebounding from its recent losses as it denied a report that it had overstated the size of its advertising network.
Brocade Communications Systems, Inc. (NASDAQ:BRCD) gained 0.59 (13.17%) to finish at $5.07 after the company said that it earned 16 cents a share on revenue of $550 million in its fourth quarter. The company said it expects revenue in a range of $530 million to $550 million in its fiscal first quarter. That compares to estimates of $541 million from analysts in a Bloomberg survey.
Canadian Solar Inc. (NASDAQ:CSIQ climbed 0.28 (12.73%) to end at $2.48, rebounding from its 52-week low of $2.07. The company swung to a third-quarter net loss from a year-earlier profit on 32% higher revenue. The net loss was US$43.9 million, or $1.02 a share, compared with net income of $20.3 million, or 47 cents, in the year-earlier period. Revenue reached $499.6 million from $377.2 million.
About InvestorIdeas.com:
InvestorIdeas.com is a leader in investor stock research by sector. Sectors we cover include; cleantech and renewable energy stocks, biotech stocks, mining and gold stocks, energy stocks, water, tech, defense stocks, nanotech, agriculture and gaming.
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Investor Research Tools;
Get Free investor news and stock alerts
Sign Up: http://www.investorideas.com/Resources/Newsletter.asp
Join Investor Ideas Get 13 of the best stock directories online;
Research oil and gas stocks, gold stocks, water stocks, renewable energy stocks (over 1300 green stocks in directory) and more
Join: http://www.investorideas.com/membership/
Follow Investorideas.com on Twitter http://twitter.com/#!/Investorideas
Follow Investorideas.com on Facebook http://www.facebook.com/Investorideas
Disclaimer: Our sites do not make recommendations. Nothing on our sites should be construed as an offer or solicitation to buy or sell products or securities. We attempt to research thoroughly, but we offer no guarantees as to the accuracy of information presented. All Information relating to featured companies is sourced from public documents and/ or the company and is not the opinion of our web sites. This site is currently compensated by featured companies, news submissions and online advertising . www.InvestorIdeas.com/About/Disclaimer.asp
800-665-0411
Source - www.Investorideas.com

InvestorIdeas.com Newswire